Despite its proinflammatory role, IFN-γ reduced cartilage damage and downregulated cFLIPL expression, suggesting its therapeutic potential in RA by inhibiting necroptosis and reducing inflammation [99]. This evidence concerns the gene IFNG and rheumatoid arthritis.